Core Laboratories
CLB
195 hedge funds and large institutions have $1.78B invested in Core Laboratories in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 68 increasing their positions, 56 reducing their positions, and 23 closing their positions.
115% more call options, than puts
Call options by funds: $6.58M | Put options by funds: $3.06M
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
44% more capital invested
Capital invested by funds: $1.24B → $1.78B (+$539M)
21% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 56
7% more funds holding
Funds holding: 183 → 195 (+12)
5.53% more ownership
Funds ownership: 93.07% → 98.61% (+5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$95.7M |
| 2 |
VanEck Associates
New York
|
+$39.2M |
| 3 |
Morgan Stanley
New York
|
+$16.9M |
| 4 |
AC
AKO Capital
London,
United Kingdom
|
+$12.5M |
| 5 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
+$9.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$16.8M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
-$15.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$13.7M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$11.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$10.7M |
CLB Hedge Fund Activity: Q2 2021 in Review
195 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2021, worth a combined $1.78B — up 44% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new CLB positions and 23 closed out — a net gain of 13 holders — while 68 added to existing stakes and 56 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $95.7M. The largest seller was Massachusetts Financial Services, cutting an estimated $16.8M.
- 195 institutional investors held Core Laboratories (CLB) as of Q2 2021, up from 183 in Q1 2021.
- Funds reported $1.78B of Core Laboratories stock for Q2 2021, up 44% quarter-over-quarter.
- 36 funds opened new Core Laboratories positions in Q2 2021 and 23 closed out, a net change of +13 holders.
- The largest Core Laboratories buyer in Q2 2021 was Fred Alger Management, an estimated $95.7M added.
- The largest Core Laboratories seller in Q2 2021 was Massachusetts Financial Services, an estimated $16.8M sold.
Based on aggregated 13F filings for Q2 2021.